We would love to hear your thoughts about our site and services, please take our survey here.
apologies for speaking eddie. i've been invested in boil for years. i havent posted for a long time here and rarely on my other investments as i honestly cant be ****d.
it would just be nice to see the coverage combined with mgmt delivering some positive news creating some sort of material and sustainable rise for the sp. we were miles higher in the not so distant past.
Imo, this makes things interesting tomorrow.
Any update on chudditch would be welcome at this point, but Dunrobbin suddenly comes heavily into focus and gives BOIL a huge uplift in visibility.
See if the wider world considers BOIL a (speculative but) highly compelling and rewarding investment proposition.
Patient sign-up will take as long as it takes. I expect it will be a few months.
Looking forward to seeing who our trial partner is though once we get FDA approval to proceed. Id like to think we will get breakthrough therapy status if we can cure AML without the need for chemo or radiotherapy. Stand alone treatment seems to be very rare still.
We shall see how things unfold! Exciting times.
The rise doesn’t have to be immediate.
HEMO has ticked another milestone off.
They are huge strides closer to owning a multi multi million dollar drug. Most drugs fail pre clinical.
HEMO marches towards to success. The door is open to huge growth. The clock is ticking til the SO explodes.
You’ll be back on Twitter when you’ve bought back in waxing lyrical and kissing Vlad’s ass ;-)
Where have you been for he last couple of days Stu? Twitter? Sold up and on the whiny whine now. Like reading a book ;-)
One2one, Addressing the current situation, HEMO is a stones throw from going clinical with a new CAR T treatment for leukemia. Whether you like it or not! Deal with it!
Excellent discovery in terms of your reading.
We have worked with both J&J and their subsidiary Jansssen. Existing links make this a situation that is not out of the question.
The potential for a multi-bag here over the next weeks are impossible to ignore.
From the RNS
"Once the clinical investigation plan proposed in the IND submission has been cleared to proceed by the FDA, the Company plans to initiate a Phase I clinical trial of HEMO-CAR-T."
Positive language from Vlad, 'once', not 'if'.. After checking the app for months he's very confident hes got it all spot on. The language also reflects the nature of FDAs checks at this stage. After having ongoing dialogue with FDA during the pre IND app process they will know exactly how HEMO are looking with all of the requirements as well as HEMO knowing they they have met all that has been asked of them by the FDA in terms of the app.
Time to buy a few more.
Stu's right...
It's utter madness to consider that the SP might go up when HEMO unlock the door to trials and potential commercialisation. Plus all the other comms that will follow. It's obviously going to be such a negative period. (This sarcasm, to be clear)
Lol
Its red or black if you dont do any research. Imo.
We will get there. Whatever waffle is peddled on here. Timescales are frustrating, this is undeniable. It takes a long time to create true innovation.
Is it worth a few years wait if your stock 10/20 bags and more? You tell me. If you trust your research and that HEMO has the magic combination, then whatever timescales are required to deliver are justified.
It makes sense to many of us humble, nobody investors that, if at all possible, HEMO would be applying for whatever grants they are able to get their hands on.
Maybe they are waiting til the CAR T IND app is submitted and work is completed with this task before beginning another project like meeting the grant requirements? Maybe reaching the clinic with CAR T will open up some doors with the obtaining of some material non-dilutive funding?
Choosing not to apply for essentially 'free funding' would be a very odd play for such a prudent man as Vlad.